Other Resources

Explore Resources Designed to Enhance Your Practice and Support Ongoing Professional Development

These tools have been developed with the highest level of dedication to support your work in improving patient outcomes. By accessing these resources, you’ll gain insights into advancements in immunotherapy, actionable strategies for clinical implementation, and collaboration opportunities that foster professional growth.

Introduction to ctDNA Testing

This section discusses using ctDNA for monitoring the response to checkpoint inhibitors in patients with cancer. It provides the rationale for using liquid biopsies, reviews the data to support it, has case examples illustrating its use, and offers practical guidance on the test.

Special thanks to George Ansstas, MD, Associate Professor in the Oncology Division at Washington University School of Medicine in Saint Louis, for contributing to this content.

[Read the Full Resource]

AIM with Immunotherapy Facebook Group

Join the conversation in the AIM with Immunotherapy Facebook group! This private, collaborative community offers a unique space for healthcare professionals to:

  • Explore cutting-edge research.
  • Share insights on treatment strategies.
  • Discuss questions and challenges with peers.
  • Build connections with others dedicated to advancing immunotherapy and patient care.

Open to oncologists, nurses, pharmacists, and other healthcare providers, this group is your space to collaborate, learn, and grow together.

[Join the AIM Facebook Group]

Addressing Health Care Disparities

This section provides strategies to improve care equity in immunotherapy. This resource features insights from:

  • Lisa Ha, MSN, APRN, CNP, of Northwestern University Memorial Hospital in Chicago, Illinois, and
  • Massey Nematollahi, RN, MScN, CNS, CON©, OCN, Immuno-Oncology Clinical Nurse Specialist at William Osler Health System in Ontario, Canada.

Explore:

  • Practical approaches to overcoming barriers in access to checkpoint inhibitors.
  • Culturally competent education strategies for managing immune-related adverse events (irAEs).

[Explore Strategies for Equitable Care]